Elzonris receives FDA approval for the treatment of blastic plasmacytoid dendritic cell neoplasm Dec. 24, 2018
FDA grants accelerated approval to Vitrakvi for advanced solid tumors with NTRK gene fusion Nov. 27, 2018
RSS